Clinical Research Directory
Browse clinical research sites, groups, and studies.
Immunophenotype of PBMC to Early Predict Response to Immunotherapy in Hepatocellular Carcinoma
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
Summary
The study is aimed to test the performance of a simple, easy, reproducible cytofluorimetric assay to complement imaging studies for: * predicting response to immune-therapeutic regimens in HCC in the early phase of treatment, * to rule out pseudo-progression, * to early predict the escape from effectiveness of treatment.
Official title: Immunophenotype of Peripheral Blood Mononuclear Cells to Early Predict Response to Immunotherapy in Hepatocellular Carcinoma
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2024-09-15
Completion Date
2028-10-15
Last Updated
2025-01-16
Healthy Volunteers
No
Conditions
Interventions
Immunochemotherapy combined with antiangiogenic
Immunochemotherapy combined with antiangiogenic
Locations (1)
IRCCS-Azienda Ospedaliero-Universitaria di Bologna
Bologna, Laura Gramantieri, Italy